Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :iii

    

• Review Articles

  • ·Prescription of inhalers in asthma and COPD: Towards a rational, rapid and effective approach

    Page :1817-1821

    P.N.R. Dekhuijzen, W. Vincken, J.C. Virchow, N. Roche, A. Agusti, F. Lavorini, W.M. van Aalderen, D. Price

    Résumé Résumé Plan Plan  
  • ·Mounier-Kuhn syndrome or congenital tracheobronchomegaly: A literature review

    Page :1822-1828

    Eduards Krustins, Zaiga Kravale, Atis Buls

    Résumé Résumé Plan Plan  

• Original Articles

  • ·Age at asthma onset and subsequent asthma outcomes among adults with active asthma

    Page :1829-1836

    Maria C. Mirabelli, Suzanne F. Beavers, Arjun B. Chatterjee, Jeanne E. Moorman

    Résumé Résumé Plan Plan  
  • ·Urinary CC16 after challenge with dry air hyperpnoea and mannitol in recreational summer athletes

    Page :1837-1844

    Pascale Kippelen, Ellen Tufvesson, Leena Ali, Leif Bjermer, Sandra D. Anderson

    Résumé Résumé Plan Plan  
  • ·Biomass fuel use and the risk of asthma in Nigerian children

    Page :1845-1851

    Jesse D. Thacher, Anders Emmelin, Aboi J.K. Madaki, Tom D. Thacher

    Résumé Résumé Plan Plan
  • ·Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes

    Page :1852-1858

    Kristian Aasbjerg, Christian Torp-Pedersen, Allan Vaag, Vibeke Backer

    Résumé Résumé Plan Plan  
  • ·Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis

    Page :1859-1865

    A. Scaife, D. Miller, D. Spiteri-Cornish, S.W. Turner, G.S. Devereux, G.M. Walsh

    Résumé Résumé Plan Plan  
  • ·Serum low density lipoprotein subclasses in asthma

    Page :1866-1872

    Nicola Scichilone, Manfredi Rizzo, Alida Benfante, Roberta Catania, Rosaria Vincenza Giglio, Dragana Nikolic, Giuseppe Montalto, Vincenzo Bellia

    Résumé Résumé Plan Plan  
  • ·The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing

    Page :1873-1880

    Rodger D. Kempsford, Amanda Oliver, Joanne Bal, Lee Tombs, Dean Quinn

    Résumé Résumé Plan Plan  
  • ·Prognostic value of six minute walk test in cystic fibrosis adults

    Page :1881-1887

    Clémence Martin, Jeanne Chapron, Dominique Hubert, Reem Kanaan, Isabelle Honoré, Jean-Louis Paillasseur, Frédérique Aubourg, Anh-Tuan Dinh-Xuan, Daniel Dusser, Isabelle Fajac, Pierre-Régis Burgel

    Résumé Résumé Plan Plan  
  • ·Measuring habitual physical activity in adults with cystic fibrosis

    Page :1888-1894

    Daniela Savi, Serena Quattrucci, Mattia Internullo, Riccardo V. De Biase, Peter M.A. Calverley, Paolo Palange

    Résumé Résumé Plan Plan   
  • ·Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells

    Page :1895-1903

    Sergio Scrimini, Jaume Pons, Alvar Agustí, Joan B. Soriano, Borja G. Cosio, Juan A. Torrecilla, Belén Núñez, Rocío Córdova, Amanda Iglesias, Andreas Jahn, Catalina Crespi, Jaume Sauleda

    Résumé Résumé Plan Plan  
  • ·Annual rates of change in pre- vs. post-bronchodilator FEV₁ and FVC over 4 years in moderate to very severe COPD

    Page :1904-1911

    Donald P. Tashkin, Ning Li, David Halpin, Eric Kleerup, Marc Decramer, Bartolome Celli, Robert Elashoff

    Résumé Résumé Plan Plan   
  • ·A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium

    Page :1912-1922

    Antonio Anzueto, Dennis E. Niewoehner, Inge Leimer, Fee Rühmkorf, Bartolome R. Celli, Marc Decramer, Donald P. Tashkin

    Résumé Résumé Plan Plan   
  • ·The relation of circulating YKL-40 to levels and decline of lung function in adult life

    Page :1923-1930

    Stefano Guerra, Marilyn Halonen, Duane L. Sherrill, Claire Venker, Amber Spangenberg, Anne-elie Carsin, Lluïsa Tarès, Iris Lavi, Esther Barreiro, Jesús Martínez-Moratalla, Isabel Urrutia, Jordi Sunyer, Josep M. Antó, Fernando D. Martinez

    Résumé Résumé Plan Plan   
  • ·Health economic costs of COPD in Sweden by disease severity – Has it changed during a ten years period?

    Page :1931-1938

    Sven-Arne Jansson, Helena Backman, Anna Stenling, Anne Lindberg, Eva Rönmark, Bo Lundbäck

    Résumé Résumé Plan Plan   
  • ·Factor analysis in predominantly severe COPD: Identification of disease heterogeneity by easily measurable characteristics

    Page :1939-1947

    Dirkje S. Postma, Antonio R. Anzueto, Christine Jenkins, Barry J. Make, Thomas Similowski, Ollie Östlund, Göran S. Eriksson, Peter M. Calverley

    Résumé Résumé Plan Plan   
  • ·Improving physical activity in patients with COPD with urban walking circuits

    Page :1948-1956

    Eulogio Pleguezuelos, María Engracia Pérez, Lluís Guirao, Beatriz Samitier, Pilar Ortega, Xavier Vila, Margarita Solans, Ariadna Riera, Eva Moreno, Alex Merí, Marc Miravitlles

    Résumé Résumé Plan Plan  
  • ·Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD

    Page :1957-1965

    Arthur F. Gelb, Donald P. Tashkin, Barry J. Make, Xiaoyun Zhong, Esther Garcia Gil, Cynthia Caracta, on behalf of the LAS-MD-35 study investigators

    Résumé Résumé Plan Plan  
  • ·Pulmonary outcome and its correlates in school-aged children born with a gestational age ? 32 weeks

    Page :1966-1976

    Marie-Luce Choukroun, Hala Feghali, Sandrine Vautrat, Fabienne Marquant, Fabienne Nacka, Valériane Leroy, Jean- Louis Demarquez, Michaël J. Fayon

    Résumé Résumé Plan Plan   
  • ·Differences between physician and patient in the perception of symptoms and their severity in COPD

    Page :1977-1985

    Marc Miravitlles, Jaume Ferrer, Eva Baró, Marta Lleonart, Jordi Galera

    Résumé Résumé Plan Plan  
  • ·Annual changes in pulmonary function in combined pulmonary fibrosis and emphysema: Over a 5-year follow-up

    Page :1986-1992

    Yoshiaki Kitaguchi, Keisaku Fujimoto, Ryoichi Hayashi, Masayuki Hanaoka, Takayuki Honda, Keishi Kubo

    Résumé Résumé Plan Plan  
  • ·A symptom-limited incremental step test determines maximum physiological responses in patients with chronic obstructive pulmonary disease

    Page :1993-1999

    Simone Dal Corso, Anderson Alves de Camargo, Meyer Izbicki, Carla Malaguti, Luiz Eduardo Nery

    Résumé Résumé Plan Plan  
  • ·The recent multi-ethnic global lung initiative 2012 (GLI₂₀₁₂) reference values don't reflect contemporary adult's North African spirometry

    Page :2000-2008

    Helmi Ben Saad, Mohamed Nour El Attar, Khaoula Hadj Mabrouk, Ahmed Ben Abdelaziz, Ahmed Abdelghani, Mohamed Bousarssar, Khélifa Limam, Chiraz Maatoug, Hmida Bouslah, Ameur Charrada, Sonia Rouatbi

    Résumé Résumé Plan Plan   
  • ·Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients

    Page :2009-2013

    Robert P. Baughman, Elyse E. Lower

    Résumé Résumé Plan Plan  
  • ·A 6MWT index to predict O₂ flow correcting exercise induced SpO₂ desaturation in ILD

    Page :2014-2021

    Josuel Ora, Luigino Calzetta, Gabriella Pezzuto, Lucia Senis, Gregorino Paone, Alessia Mari, Silvia Portalone, Paola Rogliani, Ermanno Puxeddu, Cesare Saltini

    Résumé Résumé Plan Plan  
  • ·Are we missing opportunities to confirm the diagnosis of tuberculosis by microbial culture?

    Page :2022-2028

    Zaid Al-Nakeeb, Vandana Gupta, Christine Bell, Mark Woodhead

    Résumé Résumé Plan Plan   
  • ·Effects of the Health Transformation Programme on tuberculosis burden in Turkey

    Page :2029-2037

    Zeki Yildirim, Mustafa H. Turkkani, Hamza Bozkurt, Elif Islek, Salih Mollahaliloglu, Yasin Erkoc

    Résumé Résumé Plan Plan  
  • ·Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia

    Page :2038-2045

    Mari C. de la Torre, Ignasi Bolíbar, Montse Vendrell, Javier de Gracia, Ester Vendrell, M. José Rodrigo, Xavier Boquet, Pablo Torrebadella, Joan-Carles Yébenes, Mateu Serra-Prat, Jordi Rello, Antoni Torres, Jordi Almirall

    Résumé Résumé Plan Plan  
  • ·5-Years APAP adherence in OSA patients – Do first impressions matter?

    Page :2046-2052

    Mafalda van Zeller, Milton Severo, Ana Cristina Santos, Marta Drummond

    Résumé Résumé Plan Plan
  • ·Pulse wave amplitude reduction: A surrogate marker of micro-arousals associated with respiratory events occurring under non-invasive ventilation?

    Page :2053-2060

    Dan Adler, Pierre Olivier Bridevaux, Olivier Contal, Marjolaine Georges, Elise Dupuis-Lozeron, Elisabeth Claudel, Jean Louis Pépin, Jean Paul Janssens

    Résumé Résumé Plan Plan   
  • ·Pulmonary hypertension in obesity-hypoventilation syndrome

    Page :2061-2070

    Christoph A. Kauppert, Iris Dvorak, Florian Kollert, Frank Heinemann, Rudolf A. Jörres, Michael Pfeifer, Stephan Budweiser

    Résumé Résumé Plan Plan  
  • ·Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation

    Page :2071-2080

    C. Moermans, C. Poulet, M. Henket, C. Bonnet, E. Willems, F. Baron, Y. Beguin, R. Louis

    Résumé Résumé Plan Plan  
  • ·Survival after lung transplantation in systemic sclerosis. A systematic review

    Page :2081-2087

    Irfan Y. Khan, Lianne G. Singer, Marc de Perrot, John T. Granton, Shaf Keshavjee, Cathy Chau, Amie Kron, Sindhu R. Johnson

    Résumé Résumé Plan Plan  

• Short Communication

  • ·Incidence and outcomes of bepridil-induced interstitial pneumonia

    Page :2088-2091

    Kei Yamasaki, Kazuhiro Yatera, Shingo Noguchi, Keishi Oda, Kentarou Akata, Chinatsu Nishida, Toshinori Kawanami, Yukiko Kawanami, Hiroshi Ishimoto, Shiro Ono, Yukio Wakuta, Hiroshi Mukae

    Résumé Résumé Plan Plan

• Corrigenda

  • ·Corrigendum to “Fluticasone furoate/vilanterol (100/25; 200/25 ?g) improves lung function in COPD: A randomised trial” [Respir Med 107 (2013) 550–559]

    Page :2092-2093

    Fernando J. Martinez, Joseph Boscia, Gregory Feldman, Catherine Scott-Wilson, Sally Kilbride, Leonardo Fabbri, Courtney Crim, Peter M.A. Calverley

    
  • ·Corrigendum to “A randomised trial of fluticasone furoate/vilanterol (50/25 ?g; 100/25 ?g) on lung function in COPD” [Respir Med, 107 (2013) 560–569]

    Page :2094

    Edward M. Kerwin, Catherine Scott-Wilson, Lisa Sanford, Stephen Rennard, Alvar Agusti, Neil Barnes, Courtney Crim